Pancreatic Cancer Research

ResearcherNingxia Medical UniversityActive in the last 2 years

Bendong Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0009-0001-5618-6962; OpenAlex author ID A5066345417, A5103123801. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
9
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 3 papers · 2024: none · 2025: 2 papers

Papers 6

  1. Integrative Analysis of eQTL Genes Reveals Key Biomarkers and Mechanisms for Early Diagnosis of Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1177/11769351251400465↗
  2. Reflections and a mendelian randomization analysis of patients with vitiligo and pancreatic cancer Last author DOI 10.21203/rs.3.rs-6197588/v1↗
  3. Infection with COVID-19 promotes the progression of pancreatic cancer through the PI3K-AKT signaling pathway. First author DOI 10.1007/s12672-023-00842-9↗
  4. Obesity promotes pancreatic cancer through the ECM-PI3K-AKT signaling axis Last author DOI 10.21203/rs.3.rs-3025453/v1↗
  5. Reflections and Mendelian randomization analysis of patients with vitiligo and pancreatic cancer Last author DOI 10.21203/rs.3.rs-3696455/v1↗
  6. miR‑32‑5p suppresses the proliferation and migration of pancreatic adenocarcinoma cells by targeting TLDC1. Co-author DOI 10.3892/mmr.2021.12392↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xusheng Zhang · 4 shared papers, 2023–2025 · strength 1.11
  2. Xuebo Wang · 3 shared papers, 2023–2025 · strength 0.89
  3. Peng Wei · 1 shared paper, 2023 · strength 0.20
  4. Xusheng Zhang · 1 shared paper, 2023 · strength 0.20
  5. Guozhong Zhao · 1 shared paper, 2021 · strength 0.12
  6. Weijie Yao · 1 shared paper, 2021 · strength 0.12
  7. Zuozheng Wang · 1 shared paper, 2021 · strength 0.12
  8. Yongfeng Hui · 1 shared paper, 2021 · strength 0.12
  9. Peng Yuan · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.